在墨西哥常规临床实践中,雷尼单抗治疗糖尿病黄斑水肿的12个月结果

L. P. Orozco-Gómez, Leonor Hernández-Salazar, Vanesa Flores-Peredo, Alma L. Ortega-Villalobos, Sergio Aranda-Serna, Luis Gerardo-Ferreyra, Elisa Pérez-González, Julio Pérez-Monjaraz, Alejandra Sabina Ruiz-Franco
{"title":"在墨西哥常规临床实践中,雷尼单抗治疗糖尿病黄斑水肿的12个月结果","authors":"L. P. Orozco-Gómez, Leonor Hernández-Salazar, Vanesa Flores-Peredo, Alma L. Ortega-Villalobos, Sergio Aranda-Serna, Luis Gerardo-Ferreyra, Elisa Pérez-González, Julio Pérez-Monjaraz, Alejandra Sabina Ruiz-Franco","doi":"10.24875/rmoe.m19000080","DOIUrl":null,"url":null,"abstract":"Purpose: To evaluate visual acuity (VA) and central retinal thickness (CRT) outcomes in patients treated with ranibizumab for diabetic macular edema (DME) in a clinical setting in Mexico. Methods: A prospective, open-label, single arm study was performed on 48 eyes of 34 patients with center-involving DME at four high-specialty ISSSTE hospitals in Mexico. Patients Correspondencia: *Alejandra Sabina Ruiz-Franco Calz. Gral. Ignacio Zaragoza, 1711 Col. Ejército Constitucionalista C.P. 09220, Iztapalapa, Ciudad de México, México E-mail: asruiz222@gmail.com Disponible en internet: 01-09-2019 Rev Mex Oftalmol. 2019;93(5):238-245 www.rmo.com.mx Fecha de recepción: 04-05-2019 Fecha de aceptación: 20-06-2019 DOI: 10.24875/RMO.M19000085 0187-4519/© 2019 Sociedad Mexicana de Oftalmología. Publicado por Permanyer México. Este es un artículo Open Access bajo la licencia CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/). Si n co nt ar c on e l c on se nt im ie nt o pr ev io p or e sc ri to d el e di to r, no p od rá r ep ro du ci rs e ni f ot oc op ia rs e ni ng un a pa rt e de e st a pu bl ic ac ió n. © P er m an ye r 20 19 L.P. Orozco-Gómez, et al.: Resultados del ranibizumab en el edema macular diabético","PeriodicalId":348732,"journal":{"name":"Revista Mexicana de Oftalmología (English Edition)","volume":"43 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Twelve-month outcomes of ranibizumab for diabetic macular edema in routine clinical practice in Mexico\",\"authors\":\"L. P. Orozco-Gómez, Leonor Hernández-Salazar, Vanesa Flores-Peredo, Alma L. Ortega-Villalobos, Sergio Aranda-Serna, Luis Gerardo-Ferreyra, Elisa Pérez-González, Julio Pérez-Monjaraz, Alejandra Sabina Ruiz-Franco\",\"doi\":\"10.24875/rmoe.m19000080\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Purpose: To evaluate visual acuity (VA) and central retinal thickness (CRT) outcomes in patients treated with ranibizumab for diabetic macular edema (DME) in a clinical setting in Mexico. Methods: A prospective, open-label, single arm study was performed on 48 eyes of 34 patients with center-involving DME at four high-specialty ISSSTE hospitals in Mexico. Patients Correspondencia: *Alejandra Sabina Ruiz-Franco Calz. Gral. Ignacio Zaragoza, 1711 Col. Ejército Constitucionalista C.P. 09220, Iztapalapa, Ciudad de México, México E-mail: asruiz222@gmail.com Disponible en internet: 01-09-2019 Rev Mex Oftalmol. 2019;93(5):238-245 www.rmo.com.mx Fecha de recepción: 04-05-2019 Fecha de aceptación: 20-06-2019 DOI: 10.24875/RMO.M19000085 0187-4519/© 2019 Sociedad Mexicana de Oftalmología. Publicado por Permanyer México. Este es un artículo Open Access bajo la licencia CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/). Si n co nt ar c on e l c on se nt im ie nt o pr ev io p or e sc ri to d el e di to r, no p od rá r ep ro du ci rs e ni f ot oc op ia rs e ni ng un a pa rt e de e st a pu bl ic ac ió n. © P er m an ye r 20 19 L.P. Orozco-Gómez, et al.: Resultados del ranibizumab en el edema macular diabético\",\"PeriodicalId\":348732,\"journal\":{\"name\":\"Revista Mexicana de Oftalmología (English Edition)\",\"volume\":\"43 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-09-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista Mexicana de Oftalmología (English Edition)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.24875/rmoe.m19000080\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Mexicana de Oftalmología (English Edition)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24875/rmoe.m19000080","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目的:评估雷尼比单抗治疗糖尿病黄斑水肿(DME)患者的视力(VA)和中央视网膜厚度(CRT)结果。方法:对墨西哥四家高专科ISSSTE医院34例emd患者的48只眼睛进行了前瞻性、开放式、单臂研究。患者通信:*Alejandra Sabina ruz - franco Calz。Gral. Ignacio Zaragoza, 1711 Col. ejercito Constitucionalista C.P. 09220, Iztapalapa, Ciudad de mexico, mexico E-mail: asruiz222@gmail.com互联网:01-09-2019 Rev Mex Oftalmol. 2019;93(5):238-245 www.rmo.com.mx接收日期:04-05-2019接受日期:20-06-2019 DOI: 10.24875/RMO。M19000085 0187-4519/©2019墨西哥眼科学会。由Permanyer mexico出版。这是一篇在CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/)许可下开放获取的文章。如果n co nt ar c on l和c on nt im ie nt要么pr ev p或e sc ri to d e di答,不p 4.20 rár ep ro du rs e或f cl ot的ol op的rs和pa rt和ng和st维尼《基本法》ic ac ión .©p er惯例研究生Orozco-Gómez 19 20 m an ye r, et al .:糖尿病黄斑水肿的ranibizumab结果
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Twelve-month outcomes of ranibizumab for diabetic macular edema in routine clinical practice in Mexico
Purpose: To evaluate visual acuity (VA) and central retinal thickness (CRT) outcomes in patients treated with ranibizumab for diabetic macular edema (DME) in a clinical setting in Mexico. Methods: A prospective, open-label, single arm study was performed on 48 eyes of 34 patients with center-involving DME at four high-specialty ISSSTE hospitals in Mexico. Patients Correspondencia: *Alejandra Sabina Ruiz-Franco Calz. Gral. Ignacio Zaragoza, 1711 Col. Ejército Constitucionalista C.P. 09220, Iztapalapa, Ciudad de México, México E-mail: asruiz222@gmail.com Disponible en internet: 01-09-2019 Rev Mex Oftalmol. 2019;93(5):238-245 www.rmo.com.mx Fecha de recepción: 04-05-2019 Fecha de aceptación: 20-06-2019 DOI: 10.24875/RMO.M19000085 0187-4519/© 2019 Sociedad Mexicana de Oftalmología. Publicado por Permanyer México. Este es un artículo Open Access bajo la licencia CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/). Si n co nt ar c on e l c on se nt im ie nt o pr ev io p or e sc ri to d el e di to r, no p od rá r ep ro du ci rs e ni f ot oc op ia rs e ni ng un a pa rt e de e st a pu bl ic ac ió n. © P er m an ye r 20 19 L.P. Orozco-Gómez, et al.: Resultados del ranibizumab en el edema macular diabético
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Ocular manifestations in Lyme disease Goblet cell and dry eye: a citation network analysis Online education and dry eye disease during the COVID-19 pandemic Epidemiology of primary congenital glaucoma during 2008-2018 at the Ó?Institute of Ophthalmology Conde de Valenciana Private Assistance Foundation, IAPÓ� Schnyder crystalline dystrophy
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1